Sextortion scammers targeting young men, GLP-1 stigma + a global El Niño warning

Australians are facing a dual crisis: a surge in AI-powered sextortion scams targeting young men and a growing societal stigma around using GLP-1 weight loss drugs like Ozempic. The eSafety Commissioner, Julie Inman-Grant, reveals that over 3,300 sextortion reports have been made in Australia this year, with young men aged 18–24 disproportionately affected. Scammers use AI-generated faces and voices to impersonate attractive partners on dating apps, then threaten to expose intimate images unless money is paid—leading to severe mental health distress and even suicide. Despite law enforcement efforts, recovering funds is nearly impossible, and the criminal networks operate from overseas hubs in Nigeria and Thailand. Meanwhile, the rise of GLP-1 drugs has sparked intense judgment, with users reporting shame for 'cheating' the system despite medical necessity. Experts like Professor Gemma Sharp argue that weight stigma persists because obesity is still wrongly seen as a moral failing, not a complex medical condition. Yet, GLP-1s can be life-changing for people with PCOS, diabetes, or severe metabolic issues. The conversation reveals a deeper tension: while these drugs offer real relief, societal attitudes risk undermining their legitimacy and reinforcing fatphobia.